Tumor apelin and obesity are associated with reduced neoadjuvant chemotherapy response in a cohort of breast cancer patients

Abstract Obesity is a known factor increasing the risk of developing breast cancer and reducing disease free survival. In addition to these well-documented effects, recent studies have shown that obesity is also affecting response to chemotherapy. Among the multiple dysregulations associated with ob...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Florian Gourgue, Françoise Derouane, Cedric van Marcke, Elodie Villar, Helene Dano, Lieven Desmet, Caroline Bouzin, Francois P. Duhoux, Patrice D. Cani, Bénédicte F. Jordan
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/582848c913f2403492804f339a90a0ea
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!